'Opioid overdose deaths: Understanding the lethal interactions between benzodiazepines and opioids to develop new harm reduction strategies

“阿片类药物过量死亡:了解苯二氮卓类药物和阿片类药物之间的致命相互作用,以制定新的减少危害策略

基本信息

  • 批准号:
    MR/W029162/1
  • 负责人:
  • 金额:
    $ 118.66万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2022
  • 资助国家:
    英国
  • 起止时间:
    2022 至 无数据
  • 项目状态:
    未结题

项目摘要

Drug-related deaths are now at the highest ever recorded in the UK and the highest rate in Europe. In 2020 there were nearly 1200 opioid poisoning deaths - involving heroin or methadone or other opioids - in Scotland and over 2200 in England. Many opioid users take other drugs as well - called poly-drug use - and the combination of opioids and benzodiazepines (colloquially known as benzos) has been identified as one possible reason for the increase in overdose deaths in the UK. In recent years, there has been a rise in the availability and use of illicit or "street" benzos such as Etizolam. In Scotland, there has been a doubling of the number of opioid overdose deaths in the last five years and over 75% of the deaths involved opioids and street benzos. The way these drugs interact in the brain and how they combine to increase the risk of overdose is not known and is the primary aim of this project. Our experiments will be informed also by what people who use opioids and benzos experience and what accounts they give of how and why they take benzos and opioids together. This project brings together an experienced team of researchers from a range of disciplines including qualitative research, public health, physiology, and neuropharmacology; all with experience in studying opioid drugs. Together, we will take a co-ordinated, trans-disciplinary approach to investigate how benzos increase the risk of fatal opioid overdose.Research with drug-users - Facilitated by our collaborators and stakeholders we will recruit and interview opioid users in three locations in the UK: Glasgow the site with the largest number of opioid overdose deaths in Scotland, North East England the site with the highest rate of opioid overdose deaths in England and Bristol an area with a high prevalence of opioid use but below average number of overdose deaths. Our interviews will explore in detail how people use benzos alongside opioids and why? When do they take each drug and at what doses? What is understood and experienced of the risks of overdose? Are specific benzos thought to be more likely to cause overdose? These findings will provide important information to our stakeholders and will also aid in the design of subsequent laboratory experiments aimed at determining how benzos increase the risk of fatal opioid overdose. Laboratory research - Opioid drugs act on specific targets in the brain, called mu-opioid receptors, while benzos act at a different target, the GABAA receptor. Both types of receptors exist throughout the brain but the risk of overdose results from their actions on the brain cells responsible for controlling breathing (called respiratory neurons) which can be depressed or slowed to the point that not enough oxygen is taken in and a person has a fatal overdose. There are several potential mechanisms by which benzos can increase the negative effect of opioids on breathing. Possible mechanisms include:- At the receptor level: both drugs may interact directly at the opioid receptor. For example. benzos might reverse tolerance to opioids, thus enhancing their depressant effects on breathing.- At the level of brain cells: both drugs may also act at individually their respective receptors in the same brain cell (a respiratory neuron) to enhance its depression.- At the brain level: both drugs could combine their effects on different brainstem areas that control airway and chest muscles, which would also work together to depress breathing.All these possible mechanisms would act to increase the risk of opioid overdose and will be investigated in this project. By determining how and why benzos increase the risk of fatal opioid overdose we will then work with our research partners, local and national government agencies and drug treatment agencies to develop better harm reduction strategies. In the longer term our findings may pave the way towards novel treatments to prevent fatal overdose.
目前,与毒品相关的死亡人数是英国有记录以来最高的,也是欧洲最高的。2020年,苏格兰有近1200例阿片类药物中毒死亡-涉及海洛因或美沙酮或其他阿片类药物-英格兰有2200多例。许多阿片类药物使用者服用其他药物-所谓的多种药物使用-阿片类药物和苯二氮卓类药物(俗称苯并二氮卓类药物)的组合已被确定为英国过量死亡增加的一个可能原因。近年来,非法或“街头”苯并类药物如依替唑仑的供应和使用有所增加。在苏格兰,过去五年中阿片类药物过量死亡人数翻了一番,超过75%的死亡涉及阿片类药物和街头苯佐。这些药物在大脑中相互作用的方式以及它们如何联合收割机增加过量的风险尚不清楚,这是本项目的主要目的。我们的实验也将了解使用阿片类药物和苯并类药物的人的经历,以及他们如何以及为什么同时服用苯并类药物和阿片类药物。该项目汇集了来自一系列学科的经验丰富的研究人员团队,包括定性研究,公共卫生,生理学和神经药理学;所有这些都具有研究阿片类药物的经验。我们将共同采取协调的跨学科方法来调查苯并类药物如何增加致命阿片类药物过量的风险。与吸毒者的研究-在我们的合作者和利益相关者的推动下,我们将在英国的三个地点招募和采访阿片类药物使用者:格拉斯哥是苏格兰阿片类药物过量死亡人数最多的地方,英格兰东北部是英格兰阿片类药物过量死亡率最高的地区,布里斯托是阿片类药物使用率高但过量死亡人数低于平均水平的地区。我们的采访将详细探讨人们如何使用苯并类药物以及为什么?他们什么时候服用每种药物,剂量是多少?对药物过量风险的理解和经验是什么?是否认为特定的苯类药物更有可能导致过量?这些发现将为我们的利益相关者提供重要信息,并有助于设计后续的实验室实验,旨在确定苯并类药物如何增加致命阿片类药物过量的风险。实验室研究-阿片类药物作用于大脑中的特定靶点,称为μ阿片受体,而苯并类药物作用于不同的靶点,GABAA受体。这两种类型的受体存在于整个大脑中,但过量的风险来自于它们对负责控制呼吸的脑细胞(称为呼吸神经元)的作用,这些脑细胞可能会被抑制或减缓到没有足够的氧气被摄入的程度,一个人会有致命的过量。有几种潜在的机制可以增加阿片类药物对呼吸的负面影响。可能的机制包括:-在受体水平:两种药物可能直接在阿片受体上相互作用。比如苯类药物可能会逆转对阿片类药物的耐受性,从而增强其对呼吸的抑制作用。在脑细胞水平:这两种药物也可以单独作用于同一脑细胞(呼吸神经元)中各自的受体,以增强其抑制作用。在大脑层面:这两种药物可以联合收割机它们对控制气道和胸部肌肉的不同脑干区域的作用,这些区域也会共同作用抑制呼吸。2所有这些可能的机制都将增加阿片类药物过量的风险,并将在本项目中进行研究。通过确定苯并类药物如何以及为什么会增加致命性阿片类药物过量的风险,我们将与我们的研究合作伙伴,地方和国家政府机构以及药物治疗机构合作,制定更好的减少危害策略。从长远来看,我们的研究结果可能为预防致命过量的新疗法铺平道路。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Graeme Henderson其他文献

Comparison of cannabinoids in hair with self‐reported cannabis consumption in heavy, light and non‐cannabis users
重度、轻度和非大麻使用者头发中大麻素与自我报告的大麻消费量的比较
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    M. Taylor;R. Lees;Graeme Henderson;A. Lingford;J. Macleod;J. Sullivan;M. Hickman
  • 通讯作者:
    M. Hickman
Reply to Wang and Sadée
  • DOI:
    10.1007/s00213-015-3900-7
  • 发表时间:
    2015-03-11
  • 期刊:
  • 影响因子:
    3.300
  • 作者:
    Graeme Henderson;Edward T. Bullmore
  • 通讯作者:
    Edward T. Bullmore
Coincident signalling between the Gi/Go‐coupled δ‐opioid receptor and the Gq‐coupled m3 muscarinic receptor at the level of intracellular free calcium in SH‐SY5Y cells
SH-SY5Y细胞中细胞内游离钙水平上Gi/Go偶联的δ-阿片受体和Gq偶联的m3毒蕈碱受体之间的一致信号传导
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    A. Yeo;Damien S. K. Samways;C. E. Fowler;F. Gunn;Graeme Henderson
  • 通讯作者:
    Graeme Henderson
A comparative study of the harms of nitrous oxide and poppers using the MCDA approach
使用MCDA方法比较一氧化二氮和poppers的危害
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    P. Ferreira;A. Winstock;A. Schlag;B. Brandner;Graeme Henderson;Ian Miller;J. V. van Amsterdam;L. Phillips;Polly Taylor;R. Gittins;S. Rolles;W. Brink;D. Nutt
  • 通讯作者:
    D. Nutt
harm of non-medically used prescription
非医疗用途处方药的危害
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. V. Amsterdam;annette Dale;Graeme Henderson;J. Bell;;Jones;R. Hammersley;John Ramsey;Polly Taylor;L. Phillips;J. Melichar;W. Brink;D. Nutt
  • 通讯作者:
    D. Nutt

Graeme Henderson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Graeme Henderson', 18)}}的其他基金

Fentanyl Overdose Deaths: Underlying Mechanisms
芬太尼过量死亡:潜在机制
  • 批准号:
    MR/S010890/1
  • 财政年份:
    2019
  • 资助金额:
    $ 118.66万
  • 项目类别:
    Research Grant
How does ethanol alter opioid tolerance?
乙醇如何改变阿片类药物耐受性?
  • 批准号:
    MR/J013269/1
  • 财政年份:
    2012
  • 资助金额:
    $ 118.66万
  • 项目类别:
    Research Grant

相似海外基金

The DOVE Device to Prevent Opioid Overdose Deaths: An Armband That Senses Overdose and Automatically Injects Naloxone
防止阿片类药物过量死亡的 DOVE 装置:可感应过量并自动注射纳洛酮的臂带
  • 批准号:
    10485568
  • 财政年份:
    2023
  • 资助金额:
    $ 118.66万
  • 项目类别:
Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths Within Syringe Service Programs
改善纳洛酮的公平获取,以防止注射器服务计划中阿片类药物过量死亡
  • 批准号:
    10699958
  • 财政年份:
    2022
  • 资助金额:
    $ 118.66万
  • 项目类别:
Creating a novel place-based measure to explain racial disparities in naloxone access to reduce opioid overdose deaths
创建一种新颖的基于地点的措施来解释纳洛酮获取方面的种族差异,以减少阿片类药物过量死亡
  • 批准号:
    10567710
  • 财政年份:
    2022
  • 资助金额:
    $ 118.66万
  • 项目类别:
Creating a novel place-based measure to explain racial disparities in naloxone access to reduce opioid overdose deaths
创建一种新颖的基于地点的措施来解释纳洛酮获取方面的种族差异,以减少阿片类药物过量死亡
  • 批准号:
    10710215
  • 财政年份:
    2022
  • 资助金额:
    $ 118.66万
  • 项目类别:
Harmonizing Multiple Data Sources And Psychological Autopsy To Characterize Suicides Among Opioid-Related Deaths
协调多个数据源和心理尸检来描述阿片类药物相关死亡中的自杀特征
  • 批准号:
    10426651
  • 财政年份:
    2022
  • 资助金额:
    $ 118.66万
  • 项目类别:
Harmonizing Multiple Data Sources And Psychological Autopsy To Characterize Suicides Among Opioid-Related Deaths
协调多个数据源和心理尸检来描述阿片类药物相关死亡中的自杀特征
  • 批准号:
    10623253
  • 财政年份:
    2022
  • 资助金额:
    $ 118.66万
  • 项目类别:
Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths Within Syringe Service Programs
改善纳洛酮的公平获取,以防止注射器服务计划中阿片类药物过量死亡
  • 批准号:
    10371315
  • 财政年份:
    2022
  • 资助金额:
    $ 118.66万
  • 项目类别:
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
开发用于输送纳洛酮的植入式闭环系统,以预防阿片类药物相关的过量死亡
  • 批准号:
    10022117
  • 财政年份:
    2019
  • 资助金额:
    $ 118.66万
  • 项目类别:
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
开发用于输送纳洛酮的植入式闭环系统,以预防阿片类药物相关的过量死亡
  • 批准号:
    10456452
  • 财政年份:
    2019
  • 资助金额:
    $ 118.66万
  • 项目类别:
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
开发用于输送纳洛酮的植入式闭环系统,以预防阿片类药物相关的过量死亡
  • 批准号:
    9902945
  • 财政年份:
    2019
  • 资助金额:
    $ 118.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了